#

Osteoarthritis

  • Compensation to be determined
  • 13 visits (enrollment open)
#

18+ Years

#
Male or Female
#
Smoker & Non-Smoker

Description

This is a 2-stage, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Dose and Treatment Effect of Subcutaneous Injection Pentosan Polysulfate Sodium Compared with Placebo in Adult Participants with Knee Osteoarthritis Pain. The study duration will be up to 31 weeks, treatment duration will be 6 weeks, visit frequency will be twice weekly during treatment and visit frequency will be every 4 weeks during the follow-up period. 

Participants must be 18 years of age or older, with a clinical diagnosis of osteoarthritis of the knee, suffering moderate to severe knee pain, who were unresponsive to conservative therapy within the last 6 months and willing to stop treatment with all other systemic pain medications for the duration of the trial.

Is this not what you are looking for?
Check out our other studies.

Related Studies

#

COPD

  • Compensation to be determined
  • 12 clinic visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Osteoarthritis

  • Compensation to be determined
  • clinic visits 18
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Atopic Dermatitis

  • Compensation to be determined
  • 8 clinic visits and 2 phone visits
#

A. ≥ 12yo to <18, weight > 40kg (adolescent group)
B. ≥ 18yo (adult group)

#
Male or Female
#
Smoker & Non-Smoker
© 2023 Access Research Institute. All Rights Reserved